Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 21 for

Edit search filters
  1. Quantitative Assessment of Skin and Liver of Patients with Diffuse Systemic Sclerosis Using Shear-Wave Ultrasound Elastography

    Scottsdale/Phoenix, AZ

  2. A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

    Rochester, MN

  3. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis

  4. Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD)

  5. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

    Rochester, MN

  6. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis

    Rochester, MN

  7. GUt Microbiome In Early and Established Scleroderma Study

    Rochester, MN

  8. A Registry to Track Scleroderma Progression

    Rochester, MN

  9. Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

    Jacksonville, FL

  10. Assessment of Sleep Disorder Breathing Risk in Patients with Scleroderma

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer